Inventor · disambiguated record
Alan M. Ezrin
Also filed as: EZRIN ALAN · EZRIN ALAN M
35 granted patents·18 pending applications·2,063 citations·filing 1989–2023
98Inventor score
Top patents by PatentIndex Score
53 records- 0198US7256253B2Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM BIOTECHNOLOGIES INC·Filed 2005·Granted Aug 14, 2007·105 cites·2 claims
- 0298US6887470B1Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM INC·Filed 2000·Granted May 3, 2005·210 cites·9 claims
- 0398US6849714B1Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM INC·Filed 2000·Granted Feb 1, 2005·254 cites·13 claims
- 0498US6514500B1Long lasting synthetic glucagon like peptide {GLP-!}CONJUCHEM INC·Filed 2000·Granted Feb 4, 2003·219 cites·2 claims
- 0598US6329336B1Long lasting insulinotropic peptidesCONJUCHEM INC·Filed 2000·Granted Dec 11, 2001·255 cites·14 claims
- 0697US6887849B2Long lasting synthetic glucagon-like peptide {GLP-1}CONJUCHEM INC·Filed 2002·Granted May 3, 2005·126 cites·9 claims
- 0797US6821949B2Long lasting synthetic glucagon-like peptide (GLP-1)CONJUCHEM INC·Filed 2002·Granted Nov 23, 2004·137 cites·4 claims
- 0897US6593295B2Long lasting insulinotropic peptidesCONJUCHEM INC·Filed 2001·Granted Jul 15, 2003·136 cites·29 claims
- 0995US9493810B25-ALA for detection of brain tumorsPIOMA INC·Filed 2013·Granted Nov 15, 2016·14 cites·20 claims
- 1095US6706892B1Pulmonary delivery for bioconjugationCONJUCHEM INC·Filed 2000·Granted Mar 16, 2004·151 cites·34 claims
- 1195US6500918B2Conjugate comprising an antinociceptive agent covalently bonded to a blood componentCONJUCHEM INC·Filed 2001·Granted Dec 31, 2002·40 cites·16 claims
- 1295US6277863B1Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimesCONJUCHEM INC·Filed 2000·Granted Aug 21, 2001·43 cites·4 claims
- 1393US6610825B2Method for alleviating pain or providing an analgesic effect in a patientCONJUCHEM INC·Filed 2001·Granted Aug 26, 2003·27 cites·22 claims
- 1492US6602981B2Antinociceptive agent derivativeCONJUCHEM INC·Filed 2001·Granted Aug 5, 2003·26 cites·14 claims
- 1588US8207219B2Ion channel modulating activity IFEDIDA DAVID·Filed 2010·Granted Jun 26, 2012·14 cites·10 claims
- 1686US7674820B2Ion channel modulating activity ICARDIOME PHARMA CORP·Filed 2004·Granted Mar 9, 2010·23 cites·8 claims
- 1786US6437092B1Conjugates of opioids and endogenous carriersCONJUCHEM INC·Filed 1998·Granted Aug 20, 2002·33 cites·16 claims
- 1885US11307204B25-ALA for detection of brain tumorsPIOMA INC·Filed 2019·Granted Apr 19, 2022·1 cites·13 claims
- 1985US7345086B2Uses of ion channel modulating compoundsCARDIOME PHARMA CORP·Filed 2004·Granted Mar 18, 2008·17 cites·25 claims
- 2084US7786119B2Drug conjugates of ion channel modulating compoundsCARDIOME PHARMA CORP·Filed 2005·Granted Aug 31, 2010·10 cites·6 claims
- 2184US6087375AMethods of treating or preventing thrombosesCONJUCHEM INC·Filed 1999·Granted Jul 11, 2000·48 cites·23 claims
- 2283US7507545B2Ion channel modulating activity methodCARDIOME PHARMA CORP·Filed 2004·Granted Mar 24, 2009·12 cites·1 claims
- 2383US5840733AMethods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimesREDCELL CANADA INC·Filed 1996·Granted Nov 24, 1998·42 cites·18 claims
- 2479US10877046B2Treatment of spontaneous preterm birthNX PRENATAL INC·Filed 2018·Granted Dec 29, 2020·2 cites·13 claims
- 2578US7820712B2Uses of ion channel modulating compoundsCARDIOME PHARMA CORP·Filed 2007·Granted Oct 26, 2010·2 cites·11 claims
- 2678US2022236277A1Elution of microparticles by size exclusion chromatography using water as a mobile phasePIOMA INC·Filed 2022·Application pending·0 cites
- 2777US11513125B2Microvesicle histone H2AX as a biomarker for genotoxic stressPIOMA INC·Filed 2014·Granted Nov 29, 2022·2 cites·16 claims
- 2877US5380721AAryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agentsSTERLING WINTHROP INC·Filed 1994·Granted Jan 10, 1995·17 cites·26 claims
- 2976US6440417B1Antibodies to argatroban derivatives and their use in therapeutic and diagnostic treatmentsCONJUCHEM INC·Filed 1999·Granted Aug 27, 2002·49 cites·10 claims
- 3075US5942620AMethods for producing novel conjugates of thrombin inhibitorsCONJUCHEM INC·Filed 1998·Granted Aug 24, 1999·31 cites·19 claims
- 3175US2023204593A1Microvesicle histone h2ax as a biomarker for genotoxic stressPIOMA INC·Filed 2022·Application pending·0 cites
- 3274US2024310384A1Detection of microparticle-associated proteins associated with spontaneous preterm birthNX PRENATAL INC·Filed 2023·Application pending·0 cites
- 3372US10928402B2Treatment of spontaneous preterm birthNX PRENATAL INC·Filed 2013·Granted Feb 23, 2021·2 cites·29 claims
- 3470US12429486B2Use of Tenascin-C as an extracellular marker of tumor-derived microparticlesNX PHARMAGEN INC·Filed 2022·Granted Sep 30, 2025·0 cites·7 claims
- 3567US11835530B2Detection of microparticle-associated proteins associated with spontaneous preterm birthNX PRENATAL INC·Filed 2021·Granted Dec 5, 2023·0 cites·9 claims
- 3667US2009175821A1Modified therapeutic peptides with extended half-lives in vivoBRIDON DOMINIQUE P·Filed 2007·Application pending·0 cites
- 3765US4925857APyridinyl-1H-pyrazole-1-alkanamides as antiarrhythmic agentsSTERLING DRUG INC·Filed 1989·Granted May 15, 1990·6 cites·15 claims
- 3863US5624922AAryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agentsSTERLING WINTHROP INC·Filed 1995·Granted Apr 29, 1997·9 cites·3 claims
- 3963US2017192005A15-ala for detection of brain tumorsPIOMA INC·Filed 2016·Application pending·0 cites
- 4063US2009270478A1Ion channel modulating activity iiCARDIOME PHARMA CORP·Filed 2009·Application pending·0 cites
- 4159US2016097771A1Use of tenascin-c as an extracellular marker of tumor-derived microparticlesNX Pharmagen·Filed 2014·Application pending·0 cites
- 4259US2008063707A1Controlled release tablet formulations for the prevention of arrhythmiasCARDIOME PHARMA CORP·Filed 2007·Application pending·0 cites
- 4358US2004127398A1Long lasting synthetic glucagon like peptide (GLP-1)CONJUCHEM INC·Filed 2003·Application pending·0 cites
- 4458US2004138100A1Long lasting synthetic glucagon like peptide (GLP-1)CONJUCHEM INC·Filed 2003·Application pending·0 cites
- 4553US8188140B2Uses of ion channel modulating compoundsBEATCH GREGORY N·Filed 2010·Granted May 29, 2012·0 cites·17 claims
- 4653US2009041841A1Controlled release tablet formulations for the prevention of arrhythmiasCARDIOME PHARMA CORP·Filed 2008·Application pending·0 cites
- 4753US2021270840A1Use of circulating microparticles to stratify risk of spontaneous preterm birthNX PRENATAL INC·Filed 2020·Application pending·0 cites
- 4851US2014186332A1Biomarkers of preterm birthNX Pharmagen·Filed 2013·Application pending·0 cites
- 4950US2003170250A1Local delivery of long lasting therapeutic agentsFiled 2002·Application pending·0 cites
- 5050US2004156859A1Pulmonary delivery for bioconjugationCONJUCHEM INC·Filed 2004·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alan M. Ezrin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →